released the ICH E6(R3) draft guideline for public consultation in May 2023 in collaboration with global health authorities, including the FDA. The draft revises ICH E6(R2), and regulatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback